Balyasny Asset Management’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.42M | Sell |
|
|||||
|
2025
Q1 | $7.37M | Buy |
|
|||||
|
2024
Q4 | $8M | Sell |
|
|||||
|
2024
Q3 | $20.5M | Buy |
|
|||||
|
2024
Q2 | $11.1M | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $22.1M | Sell |
|
|||||
|
2023
Q3 | $41.2M | Buy |
|
|||||
|
2023
Q2 | $40.5M | Buy |
|
|||||
|
2023
Q1 | $23.5M | Buy |
|
|||||
|
2022
Q4 | $24.4M | Buy |
|
|||||
|
2022
Q3 | $17.6M | Sell |
|
|||||
|
2022
Q2 | $23.1M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $133K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $325K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $195K | Sell |
|
|||||
|
2017
Q2 | $2.27M | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $1.64M | Buy |
|
|||||
|
2016
Q1 | $1.61M | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $15.6M | Sell |
|
|||||
|
2014
Q4 | $12.4M | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $402K | Sell |
|
|||||
|
2013
Q4 | $1.2M | Buy |
|
|||||
|
2013
Q3 | $1.13M | Buy |
|
|||||
|
2013
Q2 | $932K | Buy |
|